BECTON, DICKINSON AND COMPANY Valuation Allowance, Amount (Deprecated 2013-01-31)
BECTON, DICKINSON AND COMPANY (BDX) had Valuation Allowance, Amount (Deprecated 2013-01-31) of $26.80 million as of 2011-09-30, per its 10-K filed 2011-11-23.
Discontinued › Notes
us-gaap:ValuationAllowanceAmount · last filed 2011-11-23
- 2011-09-30: Valuation Allowance, Amount (Deprecated 2013-01-31) $26.80M.
- 2010-09-30: Valuation Allowance, Amount (Deprecated 2013-01-31) $28.00M.
| Period end | Valuation Allowance, Amount (Deprecated 2013-01-31) |
|---|---|
| 2011-09-30 | $26.80M 10-K · filed 2011-11-23 |
| 2010-09-30 | $28.00M 10-K · filed 2010-11-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |